GGrantIndex
Sort

78,016 grants matching breast cancer

Long-term Arm Morbidity Following Breast Cancer Treatment

$695,975
Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2009 · CA

Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health

$695,964
Guy H Montgomery · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Integrating Breast Cancer and Cardiovascular Disease Risk to Explore Decision-Making for Chemoprevention Among Racially/Ethnically Diverse Women at High Risk for Breast Cancer

$695,888
Rita Kukafka · Columbia University Health Sciences · R01 · FY2025 · CA

Preclinical Testing of HDAC, mTOR and MYC Inhibitors

$695,826
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

DEVELOPMENT OF NEW AGENTS FOR TREATING ENDOCRINE-RESISTANT BREAST CANCER

$695,774
Washington University, The · · FY2020 · Defense Health Agency

Project 4

$695,761
Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2015 · CA

Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization

$695,716
Michael Paasche-Orlow · Tufts Medical Center · R01 · FY2025 · CA

Characterization and prevention of Chemotherapy-Induced Damage to Ovarian Reserve

$695,670
Kutluk H Oktay · Yale University · R01 · FY2025 · HD

PREMENOPAUSAL HORMONE LEVELS AND RISK OF BREAST CANCER

$695,651
Harvard University (Sch Of Public Hlth) · U01 · FY2001 · CA

Epidemiologic Field Studies

$695,643
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors

$695,635
Ann H Partridge · Dana-Farber Cancer Inst · U01 · FY2023 · CA

Genomic and Morphologic Predictor of High-Risk DCIS

$695,617
Robert B West · Stanford University · R01 · FY2017 · CA

DECIPHERING AND INTERCEPTING MESSAGES BETWEEN CANCER CELLS AND CELLS IN THE BREAST CANCER MICROENVIRONMENT: ROLES FOR INTRACELLULAR CALCIUM SIGNALING

$695,563
The University Of Queensland · · FY2020 · Defense Health Agency

A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors

$695,558
Ann H Partridge · Dana-Farber Cancer Inst · U01 · FY2024 · CA

Enhanced Pain Coping in Cancer (EPIC)

$695,481
Jun J Mao · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma

$695,450
Peter Kuhn · University Of Southern California · U01 · FY2023 · CA

Increasing Engagement in Patient Reported Outcome Measurement to Address Breast Cancer Care Disparities using Health Information Technology in Community Cancer Settings

$695,413
Andrea Louise Pusic · Brigham And Women'S Hospital · R01 · FY2024 · CA

Genomic Risk Variants in Orofacial Clefting: Discovery and Functional Validation

$695,370
Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE

DeepTOBIDx: deep learning-enhanced multimodal diagnostic breast imaging

$695,266
Bin Deng · Massachusetts General Hospital · R01 · FY2024 · EB

APOBEC3, A HIT-AND-RUN DRIVER RESPONSIBLE FOR BREAST CANCER INITIATION AND/OR PROGRESSION?

$695,251
Hospital For Sick Children, The · · FY2024 · Defense Health Agency

DOTA-based pre-targeting of alpha emitters

$695,137
Sarah Marie Cheal · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Therapeutic and Diagnostic Factors as Related to Cancer Risk

$695,112
Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

ROLE OF THE TUMOR-IMMUNE INTERPLAY IN BREAST CANCER METASTASIS

$695,085
Virginia Commonwealth University · · FY2021 · Defense Health Agency

A2ALL- Patient Safety System Improvements in Living Donor Liver Transplantation

$695,056
Donna M Woods · Northwestern University At Chicago · R56 · FY2010 · DK

EARLY DIAGNOSIS OF CANCER: THE CANFIND CONSORTIUM

$695,047
Genetica, Inc. · U01 · FY2002 · CA